FDA approves Moderna’s next-generation Covid vaccine for adults 65 or older

A researcher works in the lab at the Moderna Inc. headquarters in Cambridge, Massachusetts, US, on Tuesday, March 26, 2024. Adam Glanzman | Bloomberg | Getty Images The U.S. Food and Drug Administration has approved Moderna’s next-generation Covid-19 vaccine for everyone aged 65 and above, the company said on Saturday, the first endorsement since the…

Stocks making the biggest moves midday: D-Wave Quantum, Moderna, Agilysys, Tesla and more

Check out the companies making headlines in midday trading. D-Wave Quantum — The quantum computing stock surged 25.9% after announcing its latest computing system called Advantage2. Agilysys — The enterprise software developer for the hospitality industry rallied 22.1% after topping analysts expectations in its latest quarter. Agilysys reported fiscal fourth-quarter adjusted EBITDA of $14.8 million,…